Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sulindac to prevent recurrent preterm labor: a randomized controlled trial.

R G Humphrey1, M C Bartfield, S J Carlan

  • 1Department of Obstetrics and Gynecology, Arnold Palmer Hospital for Children and Women, Orlando, Florida, USA.

Obstetrics and Gynecology
|September 29, 2001
PubMed
Summary

Low-dose oral sulindac did not prevent recurrent preterm labor or extend gestation in women treated for preterm labor. This study found no significant benefits in prolonging pregnancy with sulindac.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metastatic Melanoma Presenting as Multiple Cardiac Masses: The Critical Role of Endomyocardial Biopsy.

JACC. Case reports·2025
Same author

Scurvy presenting in a homeless 32-year-old male: a case report.

European journal of clinical nutrition·2024
Same author

Left anterior descending artery disease in a 27-year-old with multiple endocrine neoplasia, type 2A: A case report.

SAGE open medical case reports·2023
Same author

Oral and Lower Extremity Ulcers as the Initial Presentation of Granulomatosis with Polyangiitis.

Case reports in medicine·2022
Same author

A Large Intrathoracic Hiatal Hernia as a Cause of Complete Heart Block.

Case reports in cardiology·2021
Same author

Vaping-Induced Lung Injury: A Case of Lipoid Pneumonia Associated with E-Cigarettes Containing Cannabis.

Case reports in pulmonology·2020

Area of Science:

  • Obstetrics and Gynecology
  • Perinatal Medicine
  • Pharmacology

Background:

  • Preterm labor is a significant cause of neonatal morbidity and mortality.
  • Prolonging gestation is crucial for improving neonatal outcomes.
  • Effective tocolytic strategies are essential for managing preterm labor.

Purpose of the Study:

  • To evaluate the efficacy of low-dose oral sulindac for prolonged duration in reducing recurrent preterm labor.
  • To assess the impact of sulindac on extending gestation after initial tocolysis.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial was conducted.
  • Patients in preterm labor (24-34 weeks gestation) received intravenous magnesium sulfate.
  • Following successful tocolysis, patients received either oral sulindac (100 mg every 12 hours) or placebo until 34 weeks' gestation.

Related Experiment Videos

Main Results:

  • No significant differences were observed between the sulindac and placebo groups in terms of time gained in utero.
  • Rates of delivery after 35 weeks' gestation and recurrent preterm labor were similar between groups.
  • Birth weight and neonatal intensive care unit (NICU) stay duration did not differ significantly.

Conclusions:

  • Oral sulindac administered until 34 weeks' gestation after parenteral tocolysis did not decrease the incidence of readmission for preterm labor.
  • The study failed to demonstrate a benefit of low-dose sulindac in prolonging gestation or preventing recurrent preterm labor.